Biomarkers to Predict Aggressive Prostate Cancer
Claire Morgan discusses the need to identify a panel of biomarkers that may distinguish indolent cancer from aggressive metastatic disease when used collectively.
Contributions of Mass Spectrometry in the Diagnosis and Management of Hypothalamic–pituitary–adrenal Axis Disorders
Mass spectrometry is increasingly used in clinical laboratories for the measurement of steroid hormones. In fact, clinical biochemistry and endocrine societies emphasize in their documents the enhanced analytical specificity for mass spectrometry measurements of steroids in comparison with conventional immunoassays.
Biomarkers from Discovery to Clinical Diagnostics Applications of Single-Molecule Array (Simoa) Technology
Andreas Jeromin, Atlantic Biomarkers, speaking at Diagnostics & Biomarkers 2015.
History and Development of High Resolution Mass Spectrometry for Infectious Disease Diagnostics
This presentation will trace the continuing development of mass spectral techniques from a research tool to a frontline diagnostic platform for clinical microbiology.
A Novel Vertically-Integrated Platform for the Discovery and Molecular Characterization of Lung Cancer Stem Cells
Raj Batra, University of California Los Angeles, speaking at Diagnostics & Biomarkers 2015.
Diagnosis of Disorders Affecting Steroid Synthesis and Metabolism by Mass Spectrometry
Despite all the progress in the proteomic and genomic research, the quantitation of steroids in biological samples is still needed for the establishment of the biochemical phenotype of disorders affecting steroid biosynthesis.
Microfluidic Systems for Biomarker Analysis and Cancer Diagnosis
In this talk, Martin Gijs discusses a novel magnetic surface coverage assay and a microfluidic tissue processor with applications in cancer diagnostics.
Improvements in Molecular Diagnosis of Pathogens and Diseases
This talk offers a valuable guide to the development of LAMP in molecular detection and determination of target sequences and will present examples with bright field applications of the method from the detection of pathogens to clinical applications for the diagnosis of cancer and other disorders.